The Tokai University and Tibet University Scientific Friendship Expedition 2001 succeeded in reaching the summit of Kula Kangri (7,538 m) in the Himalrayas without supplementary O2 in May, 2001. Before this expedition, the cardiopulmonary function of all members was evaluated using a hypobaric hypoxic chamber in which the barometric pressure was gradually lowered to a simulated altitude of 6000 m. Whenever a member's PaO2 was lower than 40 torr during the experiment, supplementary O2 was given. The results were divided into two groups, Group A and Group B, according to whether supplementary O2 was used. Group A subjects did not need O2 even at an altitude of 6,000 m, whereas Group B subjects did when they reached an altitude of 5,000 m. Seven the eight Group A members had climbed mountains over 4,000 m several times, whereas twelve out of the thirteen members of Group B had no mountaineering experience. The mean PaO2 and PaCO2 of Group A at 6000 m were 41.9 torr and 31.9 torr, respectively, while those of Group B at 5000 m were 35.8 torr and 35.9 torr. There was a significant difference in the degree of hyperventilation between Group A and Group B. No difference was observed between the two groups in systolic and diastolic arterial blood pressure, but the heart rate in Group B increased significantly under hypoxia. These results suggest that the experience of climbing mountains over 4000 m may lead to significant differences in cardiopulmonary function under hypoxia.
Download full-text PDF |
Source |
---|
Wellcome Open Res
December 2024
Nepal Health Research Council, Kathmandu, Bagmati Province, Nepal.
Background: This study aimed to assess the current status of critical care services in 13 districts of Bagmati Province in Nepal, with a focus on access, infrastructure, human resources, and intensive care unit (ICU) services.
Methods: A cross-sectional survey was conducted among healthcare workers employed in 87 hospitals having medical/surgical ICUs across Bagmati Province. Data were collected through structured questionnaires administered via face-to-face and telephone interviews.
Crit Care Resusc
December 2024
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Objective: To describe the six-month functional outcomes of patients who received extracorporeal cardiopulmonary resuscitation (ECPR) following in-hospital cardiac arrest (IHCA) in Australia.
Design: Secondary analysis of EXCEL registry data.
Setting: EXCEL is a high-quality, prospective, binational registry including adult patients who receive extracorporeal membrane oxygenation (ECMO) in Australia and New Zealand.
Respir Physiol Neurobiol
January 2025
Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute of Health and Rehabilitation Science, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China. Electronic address:
The central neural mechanism plays an important role in cardiopulmonary coupling. How the brain stem affects the cardiopulmonary coupling is relatively clear, but there are few studies on the cerebral cortex activity of cardiopulmonary coupling. We aim to study the response of the cerebral cortex for cardiopulmonary phase synchronization enhancement.
View Article and Find Full Text PDFPLoS One
January 2025
Institute of Parasitology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
The cardiopulmonary nematode Angiostrongylus vasorum can cause severe disease in dogs, including coagulopathies manifesting with bleeding. We analysed A. vasorum excretory/secretory protein (ESP)-treated dog plasma and serum by N-terminome analysis using Terminal Amine Isotopic Labelling of Substrates (TAILS) to identify cleaved host substrates.
View Article and Find Full Text PDFSci China Life Sci
January 2025
Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center; Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, 100191, China.
Diffuse-type tenosynovial giant cell tumor (dTGCT) is a destructive but rare benign proliferative synovial neoplasm. Although surgery is currently the main treatment modality for dTGCT, the recurrence risk is up to 50%. Therefore, there is a great need for effective drugs against dTGCT with minor side effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!